Aditxt Inc. Strengthens Board with Appointment of Women's Health Leader Saundra Pelletier

Aditxt Inc. (NASDAQ: ADTX) has taken a significant step towards enhancing its focus on women's health by appointing Saundra Pelletier, the CEO of Evofem Biosciences (OTCPK: EVFM), to its Board of Directors. This strategic move underscores Aditxt's commitment to advancing its commercialization efforts and leveraging Pelletier's over 30 years of global pharmaceutical experience, especially in women's reproductive health.

Pelletier's track record includes leading Evofem Biosciences through the approval and commercial growth of Phexxi(R) and the acquisition of SOLOSEC(R), achievements that have contributed to four consecutive years of net sales growth. Her expertise is not limited to Evofem; she also serves on the boards of Windtree Therapeutics (NASDAQ: WINT) and several nonprofit advisory boards focused on women's empowerment and health. Her appointment is a clear indication of Aditxt's intention to strengthen its position in the health innovation sector, particularly in areas affecting women's health.

Aditxt's unique innovation platform, which collaborates with research institutions, industry partners, and shareholders, aims to democratize innovation and address significant societal health challenges. The company's current programs focus on immune health and precision health, with plans to introduce additional programs dedicated to public health and women's health. These initiatives are part of Aditxt's broader strategy to discover, develop, and deploy innovative health solutions to tackle some of the most pressing health challenges today.

The addition of Pelletier to Aditxt's Board of Directors is a pivotal development for the company as it seeks to expand its influence in the women's health sector. Her leadership and experience are expected to play a crucial role in guiding Aditxt's future endeavors, including potential mergers and acquisitions that align with its mission. This appointment not only highlights Aditxt's dedication to advancing women's health but also positions the company as a leader in health innovation, with the potential to make a significant impact on the industry and society at large.